Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Higher Physical Fitness Regulates In Vitro Tumor Cell Growth in Older Adults with Treatment Naïve Chronic Lymphocytic Leukemia (CLL)

Andrea Sitlinger, Michael A. Deal, Erwin Garcia, Dana K. Thompson, Tiffany Stewart, Grace A. MacDonald, Nicolas Devos, David Corcoran, Janet S. Staats, Jennifer Enzor, Kent J. Weinhold, Danielle M. Brander, J. Brice Weinberg, David B. Bartlett
doi: https://doi.org/10.1101/2021.03.01.21252293
Andrea Sitlinger
3Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Deal
1Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA
2Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erwin Garcia
4Laboratory Corporation of America Holdings, Morrisville, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana K. Thompson
5Division of Hematology, Duke University School of Medicine and VA Medical Center, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiffany Stewart
5Division of Hematology, Duke University School of Medicine and VA Medical Center, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace A. MacDonald
1Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA
2Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Devos
6Duke Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Corcoran
6Duke Center for Genomic and Computational Biology, Duke University, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet S. Staats
7Division of Surgical Sciences, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Enzor
7Division of Surgical Sciences, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kent J. Weinhold
7Division of Surgical Sciences, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle M. Brander
3Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Brice Weinberg
5Division of Hematology, Duke University School of Medicine and VA Medical Center, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B. Bartlett
1Division of Medical Oncology, Duke University School of Medicine, Durham, NC, USA
2Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.bartlett@duke.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Chronic lymphocytic leukemia (CLL) is associated with physical dysfunction and low overall fitness that predicts poor survival following commencement of treatment. However, it remains unknown whether higher fitness in CLL patients provides anti-oncogenic effects. We identified ten fit (CLL-FIT) and ten less fit (CLL-UNFIT) treatment-naïve CLL patients from 144 CLL patients who completed a set of physical fitness and performance tests. Patient plasma was used to determine its effects on in vitro 5-day growth/viability of three B-cell cell lines (OSU-CLL, Daudi and Farage). Plasma exosomal miRNA profiles, circulating lipids, lipoproteins, inflammation levels, and immune cell phenotypes were also assessed. CLL-FIT was associated with fewer viable OSU-CLL cells at Day 1 (p=0.003), Day 4 (p=0.001) and Day 5 (p=0.009). No differences between groups were observed for Daudi and Farage cells. Of 455 distinct exosomal miRNAs identified, 32 miRNAs were significantly different between groups. Of these, 14 miRNAs had ≤-1 or ≥1 log2 fold differences. CLL-FIT patients had 5 exosomal miRNAs with lower expression and 9 miRNAs with higher expression. CLL-FIT patients had higher HDL cholesterol, lower inflammation, and lower levels of triglyceride components (all p<0.05). CLL-FIT patients had lower frequencies of low-differentiated NKG2+/CD158a/bneg (p=0.015 and p=0.014) and higher frequencies of NKG2Aneg/CD158b+ mature NK-cells (p=0.047). Absolute numbers of lymphocytes including CD19+/CD5+ CLL-cells were similar between groups (p=0.359). Higher physical fitness in CLL patients is associated with altered CLL-like cell line growth in vitro, and with altered circulating and cellular factors indicative of better immune functions and tumor control.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a Duke Claude D. Pepper Older Americans Independence Center Pilot Study Award (National Institutes of Health, National Institute on Aging P30-AG028716), National Institutes of Health, National Heart, Lung, and Blood Institute T32 grant (T32HL007057), the Durham Veterans Affairs Medical Center Research Service, an American Society of Hematology Scholars Award, and the Duke University Center for AIDS Research NIH funded program (P30 AI 64518).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Duke University Medical Center Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets generated during the present study are not publicly available, owing to the risk of disclosure or deduction of private individual information, but they are available from the corresponding author on reasonable request.

  • Abbreviations

    6MWT
    6-minute walk test
    BCAA
    branch chain amino acid
    CBC
    complete blood count
    CD
    cluster of differentiation
    CLL
    Chronic Lymphocytic Leukemia
    CLL-IPI
    Chronic Lymphocytic Leukemia – International Prognostic Index
    DMSO
    Dimethyl sulfoxide
    DPBS
    Dulbecco’s phosphate buffered saline
    EBV
    Epstein Barr Virus
    EDTA
    Ethylenediaminetetraacetic acid
    eVO2peak
    estimated peak volume of oxygen consumption
    FBS
    fetal bovine serum
    FFA
    Free Fatty Acids
    FMO
    flow minus one
    HDL
    high-density lipoprotein
    ICAM-1
    Intercellular Adhesion Molecule 1
    IFN
    interferon
    IGHV
    immunoglobulin heavy chain variable region genes
    IL
    interleukin
    IPAQ
    Incidental and Planned Activity Questionnaire
    KIR
    Killer immunoglobulin-like receptor
    LDL
    low-density lipoprotein
    LP-IR
    Lipoprotein Insulin Resistance Index
    miRNA
    micro-RNA
    NK-cell
    Natural Killer Cell
    NKG2
    CD94/NK group 2 member
    NMR
    nuclear magnetic resonance
    OSU-CLL
    Ohio State University-Chronic Lymphocytic Leukemia
    PBMC
    peripheral blood mononuclear cell
    PI
    propidium iodide
    RNA
    ribonucleic acid
    RPMI
    Roswell Park Memorial Institute
    SBAS
    Stanford Brief Activity Survey
    SPPB
    short physical performance battery
    STAT
    Signal transducer and activator of transcription
    TGFβ
    Transforming growth factor β
    TNFα
    tumor necrosis factor α
    TRL
    triglyceride rich lipoprotein
    TRLP
    triglyceride rich lipoprotein particle
    TUG
    timed-up and go
    UMI
    Unique Molecular Indices
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted March 02, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Higher Physical Fitness Regulates In Vitro Tumor Cell Growth in Older Adults with Treatment Naïve Chronic Lymphocytic Leukemia (CLL)
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Higher Physical Fitness Regulates In Vitro Tumor Cell Growth in Older Adults with Treatment Naïve Chronic Lymphocytic Leukemia (CLL)
    Andrea Sitlinger, Michael A. Deal, Erwin Garcia, Dana K. Thompson, Tiffany Stewart, Grace A. MacDonald, Nicolas Devos, David Corcoran, Janet S. Staats, Jennifer Enzor, Kent J. Weinhold, Danielle M. Brander, J. Brice Weinberg, David B. Bartlett
    medRxiv 2021.03.01.21252293; doi: https://doi.org/10.1101/2021.03.01.21252293
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Higher Physical Fitness Regulates In Vitro Tumor Cell Growth in Older Adults with Treatment Naïve Chronic Lymphocytic Leukemia (CLL)
    Andrea Sitlinger, Michael A. Deal, Erwin Garcia, Dana K. Thompson, Tiffany Stewart, Grace A. MacDonald, Nicolas Devos, David Corcoran, Janet S. Staats, Jennifer Enzor, Kent J. Weinhold, Danielle M. Brander, J. Brice Weinberg, David B. Bartlett
    medRxiv 2021.03.01.21252293; doi: https://doi.org/10.1101/2021.03.01.21252293

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Oncology
    Subject Areas
    All Articles
    • Addiction Medicine (228)
    • Allergy and Immunology (506)
    • Anesthesia (110)
    • Cardiovascular Medicine (1245)
    • Dentistry and Oral Medicine (206)
    • Dermatology (147)
    • Emergency Medicine (282)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
    • Epidemiology (10032)
    • Forensic Medicine (5)
    • Gastroenterology (500)
    • Genetic and Genomic Medicine (2467)
    • Geriatric Medicine (238)
    • Health Economics (480)
    • Health Informatics (1647)
    • Health Policy (754)
    • Health Systems and Quality Improvement (637)
    • Hematology (250)
    • HIV/AIDS (536)
    • Infectious Diseases (except HIV/AIDS) (11872)
    • Intensive Care and Critical Care Medicine (626)
    • Medical Education (253)
    • Medical Ethics (75)
    • Nephrology (268)
    • Neurology (2290)
    • Nursing (139)
    • Nutrition (352)
    • Obstetrics and Gynecology (454)
    • Occupational and Environmental Health (537)
    • Oncology (1249)
    • Ophthalmology (377)
    • Orthopedics (134)
    • Otolaryngology (226)
    • Pain Medicine (158)
    • Palliative Medicine (50)
    • Pathology (325)
    • Pediatrics (734)
    • Pharmacology and Therapeutics (315)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2281)
    • Public and Global Health (4844)
    • Radiology and Imaging (843)
    • Rehabilitation Medicine and Physical Therapy (492)
    • Respiratory Medicine (652)
    • Rheumatology (286)
    • Sexual and Reproductive Health (241)
    • Sports Medicine (227)
    • Surgery (269)
    • Toxicology (44)
    • Transplantation (125)
    • Urology (99)